P-055. Comparison of antivirals in prophylaxis of HBV reactivation in patients receiving immunsuppressive therapy

INTRODUCTION: HBV reactivation is a serious problem in immunosuppressive (IS) treated patients. The guidelines recommend the use of nucleoside (t) id analogs to prevent reactivation in patients undergoing immunosuppressive therapy. In this study, we aimed to compare the efficacy of antivirals in pat...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Turk J Gastroenterol
Autors principals: Aladag, M., Harputluoglu, M., Caliskan, A.R., Erdogan, M.A., Bilgic, Y., Yildirim, O., Cagin, Y.F., Seckin, Y., Karincaoglu, M.
Format: Artigo
Idioma:Inglês
Publicat: Turkish Society of Gastroenterology 2019
Matèries:
AASLD - TASL CONNECT REGIONAL MEETING, March 15–16, 2019 - İstanbul, Turkey
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7021070/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/tjg.2019.61
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars